CoChat

Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status

Open access
MacKie, Rona M, Hole, David J · 1996 · BMJ
Cited by 114

The DOI matches its Crossref record.

Abstract

Objective : To study incidence of and survival from cutaneous malignant melanoma in relation to socioeconomic status. Design : Application of Carstairs deprivation score to all malignant melanoma patients diagnosed in a geographically defined area over a 15 year period. Setting : West of Scotland (area population 2 716 900). Subjects : 3142 patients first diagnosed with malignant melanoma in the period 1979-93. Interventions : Surgical excision of primary malignant melanoma with additional treatment as appropriate and follow up until December 1994. Main outcome measures : Malignant melanoma incidence, primary tumour thickness and five year survival by socioeconomic status Results : From 1979 to 1993, the age standardised incidence rate for cutaneous malignant melanoma was 9.1/100000 for the most affluent men and 2.4/100000 for the least affluent men and 16.1/100000 and 5.0/100000 respectively for most and least affluent women (P<0.001 for trend in both). The incidence increased steadily over time in both sexes in all socioeconomic groups. Good prognosis tumours (<1.5 mm thick) were most common in the most affluent men and women, and over the study period the proportion of such tumours increased most in the intermediate affluence group (both sexes) and in the least affluent women. Five year disease free survival from melanoma for the sexes combined was 81% for most affluent, 77% for intermediate, and 73% for least affluent groups. Even after adjustment for known prognostic factors of tumour thickness, ulceration, age, and body site of primary melanoma, the more affluent the group, the better the survival. Conclusion : Although the incidence of cutaneous malignant melanoma is higher among more affluent people, the prognosis is better in this group than for less affluent individuals. Early diagnosis campaigns should be targeted particularly to less affluent men and primary prevention campaigns should emphasise the greater risk in more affluent women. Key messages: Key messages Paradoxically, five year disease free survival prospects are better for affluent people Variations in incidence could be explained by differences in sun exposure related to socio- economic status Variations in nutrition and possibly immune function by socioeconomic status could explain survival differences In public education campaigns, deprived men should be targeted to encourage earlier diagnosis Primary prevention campaigns should be tar- geted to more affluent socioeconomic groups

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.312.7039.1125

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 114

Metadata

Authors
MacKie, R. M., & Hole, D. J.
Venue
BMJ
Publisher
BMJ
Published
1996-05-04
Volume
312
Issue
7039
Pages
1125-1128
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W1996331217
Cited by
114
References
0
FWCI
2.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. https://app.cochat.ai/papers/10.1136/bmj.312.7039.1125
The paper
MacKie, R. M., & Hole, D. J. (1996). Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. BMJ. https://doi.org/10.1136/bmj.312.7039.1125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.